Krystal Biotech, Inc. Common Stock vs. Tectonic Therapeutic, Inc. Common Stock
KRYS
Krystal Biotech, Inc. Common Stock
$360.03 +0.19%
VS TECXTectonic Therapeutic, Inc. Common Stock
$31.22 +4.28%
Krystal Biotech, Inc. Common Stock and Tectonic Therapeutic, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| KRYS | TECX | |
|---|---|---|
| Market Cap | $10.64 billion | $585.31 million |
| Revenue (TTM) | $440.48 million | — |
| Net Income (TTM) | $241.47 million | — |
KRYS leads on 1 of 1 size & scale factors.
Valuation
| KRYS | TECX | |
|---|---|---|
| P/E Ratio | 45.12 | — |
| Price / Book | 7.83 | — |
| Price / Sales | 24.15 | — |
KRYS and TECX split the valuation factors evenly.
Profitability
| KRYS | TECX | |
|---|---|---|
| Net Margin | 54.82% | — |
| Return on Equity | 17.77% | — |
KRYS and TECX split the profitability factors evenly.
Risk & Sentiment
| KRYS | TECX | |
|---|---|---|
| Short Interest | 0.11% | 0.09% |
TECX leads on 1 of 1 risk & sentiment factors.
Dig deeper: KRYS overview, KRYS financials, TECX overview, TECX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.